Omega-3 Fatty Acids: Possible Neuroprotective Mechanisms in the Model of Global Ischemia in Rats

Journal of Nutrition and Metabolism

Volumn 2016, Issue , 2016, Pages

  Nobre, Maria Elizabeth Pereira ^a   Correia, Alyne Oliveira ^a   Mendonça, Francisco Nilson Maciel ^a   Uchoa, Luiz Ricardo Araújo ^a   Vasconcelos, Jessica Tamara Nunes ^a   De Araújo, Carlos Ney Alencar ^a   Brito, Gerly Anne De Castro ^b   Siqueira, Rafaelly Maria Pinheiro ^b   Cerqueira, Gilberto Dos Santos ^b   Neves, Kelly Rose Tavares ^b   Arida, Ricardo Mário ^c   Viana, Glauce Socorro De Barros ^a,b  

^a Faculty of Medicine Estacio FMJ   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84975099894     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2016/6462120     Document Type: Article

References (80)

1. A. Durukan and T. Tatlisumak, "Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia," Pharmacology Biochemistry and Behavior, vol. 87, no. 1, pp. 179-197, 2007.
2. S. Braeuninger and C. Kleinschnitz, "Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems," Experimental & Translational Stroke Medicine, vol. 1, pp. 1-11, 2009.
3. M. Bacigaluppi, G. Comi, and D.M. Hermann, "Animal models of ischemic stroke. part two: modeling cerebral ischemia," The Open Neurology Journal, vol. 4, pp. 34-38, 2010.
4. Y. Huang and J.O. McNamara, "Ischemic stroke: 'Acidotoxicity' is a perpetrator," Cell, vol. 118, no. 6, pp. 665-666, 2004.
5. P. Mergenthaler, U. Dirnagl, and A. Meisel, "Pathophysiology of stroke: lessons from animal models," Metabolic Brain Disease, vol. 19, no. 3-4, pp. 151-167, 2004.
6. T. G. Phan, P. M. Wright, R. Markus, D.W. Howells, S. M. Davis, and G. A. Donnan, "Salvaging the ischaemic penumbra: more than just reperfusion?" Clinical and Experimental Pharmacology and Physiology, vol. 29, no. 1-2, pp. 1-10, 2002.
7. W. Zhang, P. Li, X. Hu, F. Zhang, J. Chen, and Y. Gao, "Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection," Frontiers in Bioscience, vol. 16, no. 7, pp. 2653-2670, 2011.
8. J. W. Phillis and M. H. O'Regan, "Characterization ofmodes of release of amino acids in the ischemic/reperfused rat cerebral cortex," Neurochemistry International, vol. 43, no. 4-5, pp. 461-467, 2003.
9. S. Chalon, S. Delion-Vancassel, C. Belzung et al., "Dietary fish oil affects monoaminergic neurotransmission and behavior in rats," Journal of Nutrition, vol. 128, no. 12, pp. 2512-2519, 1998.
10. S. Chalon, "Omega-3 fatty acids and monoamine neurotransmission," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 75, no. 4-5, pp. 259-269, 2006.
11. C. J. S. Price, E. A. Warburton, and D. K. Menon, "Human cellular inflammation in the pathology of acute cerebral ischaemia," Journal of Neurology, Neurosurgery and Psychiatry, vol. 74, no. 11, pp. 1476-1484, 2003.
12. R. Jin, G. Yang, and G. Li, "Inflammatory mechanisms in ischemic stroke: role of inflammatory cells," Journal of Leukocyte Biology, vol. 87, no. 5, pp. 779-789, 2010.
13. P. C. Calder, "Dietary modification of inflammation with lipids," Proceedings of the Nutrition Society, vol. 61, no. 3, pp. 345-358, 2002.
14. A. P. Simopoulos, "Omega-3 fatty acids in inflammation and autoimmune diseases," Journal of the American College of Nutrition, vol. 21, no. 6, pp. 495-505, 2002.
15. P. C. Calder, "Omega-3 fatty acids and inflammatory processes," Nutrients, vol. 2, no. 3, pp. 355-374, 2010.
16. P. C. Calder, "Fatty acids and inflammation: the cutting edge between food and pharma," European Journal of Pharmacology, vol. 668, no. 1, pp. S50-S58, 2011.
17. M. E. P. Nobre, A. O. Correia, M. B. Borges et al., "Eicosapentaenoic acid and docosahexaenoic acid exert anti-inflammatory and antinociceptive effects in rodents at low doses," Nutrition Research, vol. 34, pp. 251-263, 2013.
18. L. Prut and C. Belzung, "The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review," European Journal of Pharmacology, vol. 463, no. 1-3, pp. 3-33, 2003.
19. R. G. M. Morris, "Spatial localization does not require the presence of local cues," Learning and Motivation, vol. 12, no. 2, pp. 239-260, 1981.
20. C. V. Vorhees and M. T. Williams, "Morris water maze: procedures for assessing spatial and related forms of learning and memory," Nature Protocols, vol. 1, no. 2, pp. 848-858, 2006.
21. J. B. Bederson, L. H. Pitts, S. M. Germano, M. C. Nishimura, R. L. Davis, and H.M. Bartkowski, "Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats," Stroke, vol. 17, no. 6, pp. 1304-1308, 1986.
22. F. Block, "Global ischemia and behavioural deficits," Progress in Neurobiology, vol. 58, no. 3, pp. 279-295, 1999.
23. H. Hodges, A. Nelson, D. Virley, T. R. Kershaw, and J. D. Sinden, "Cognitive deficits induced by global cerebral ischaemia: prospects for transplant therapy," Pharmacology Biochemistry and Behavior, vol. 56, no. 4, pp. 763-780, 1997.
24. W.A. Pulsinelli, J. B. Brierley, and F. Plum, "Temporal profile of neuronal damage in a model of transient forebrain ischemia," Annals of Neurology, vol. 11, no. 5, pp. 491-498, 1982.
25. M. A. Atlasi, H. Naderian, M. Noureddini, E. Fakharian, and A. Azami, "The morphology of rat hippocampus CA1 neurons followingmodified two and four vessel global ischemiamodels," Archives of Trauma Research, vol. 2, no. 3, pp. 124-128, 2013.
26. I. Fedorova and N. Salem Jr., "Omega-3 fatty acids and rodent behavior," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 75, no. 4-5, pp. 271-289, 2006.
27. T. Takeuchi, M. Iwanaga, and E. Harada, "Possible regulatory mechanism of DHA-induced anti-stress reaction in rats," Brain Research, vol. 964, no. 1, pp. 136-143, 2003.
28. A. Harauma and T. Moriguchi, "Dietary n-3 fatty acid deficiency in mice enhances anxiety induced by chronic mild stress," Lipids, vol. 46, no. 5, pp. 409-416, 2011.
29. N. Vinot, M. Jouin, A. Lhomme-Duchadeuil et al., "Omega-3 fatty acids from fish oil lower anxiety, improve cognitive functions and reduce spontaneous locomotor activity in a nonhuman primate," PLoS ONE, vol. 6, no. 6, Article ID e20491, 2011.
30. H. Plamondon and M.-C. Roberge, "Dietary PUFA supplements reduce memory deficits but not CA1 ischemic injury in rats," Physiology and Behavior, vol. 95, no. 3, pp. 492-500, 2008.
31. H.-M. Su, "Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance," Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 364-373, 2010.
32. (1-40)," Journal of Nutritional Biochemistry, vol. 20, no. 12, pp. 965-973, 2009.
33. S. C. Heinrichs, "Dietary ω3 fatty acid supplementation for optimizing neuronal structure and function," Molecular Nutrition and Food Research, vol. 54, no. 4, pp. 447-456, 2010.
34. J. S. Fernandes, M. A. Mori, R. Ekuni, R. M. W. Oliveira, and H. Milani, "Long-termtreatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia," Nutrition Research, vol. 28, no. 11, pp. 798-808, 2008.
35. N. Okabe, T. Nakamura, T. Toyoshima, O. Miyamoto, F. Lu, and T. Itano, "Eicosapentaenoic acid prevents memory impairment after ischemia by inhibiting inflammatory response and oxidative damage," Journal of Stroke and Cerebrovascular Diseases, vol. 20, no. 3, pp. 188-195, 2011.
36. N. F. A. Sopian, M. Ajat, N. I. Shafie et al., "Does shortterm dietary omega-3 fatty acid supplementation influence brain hippocampus gene expression of zinc transporter-3?" International Journal of Molecular Sciences, vol. 16, no. 7, pp. 15800-15810, 2015.
37. L. G. Puskás, K. Kitajka, C. Nyakas, G. Barcelo-Coblijn, and T. Farkas, "Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 1580-1585, 2003.
38. W. Zhang, X. Hu, W. Yang, Y. Gao, and J. Chen, "Omega-3 polyunsaturated fatty acid supplementation confers longterm neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions," Stroke, vol. 41, no. 10, pp. 2341-2347, 2010.
39. X. Tang, Z.-J. Li, J. Xu et al., "Short term effects of different omega-3 fatty acid formulation on lipid metabolism in mice fed high or low fat diet," Lipids in Health and Disease, vol. 11, article 70, 2012.
40. M. Ajami, S. Eghtesadi, R. Habibey et al., "Effect of short- and long-termtreatment with Omega-3 fatty acids on scopolamineinduced amnésia," Iranian Journal of Pharmaceutical Research, vol. 11, no. 2, pp. 533-540, 2012.
41. S. K. Raatz, J. B. Redmon, N. Wimmergren, J. V. Donadio, and D. M. Bibus, "Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil," Journal of the American Dietetic Association, vol. 109, no. 6, pp. 1076-1081, 2009.
42. K. Yurko-Mauro, D. McCarthy, D. Romet al., "Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline," Alzheimer's and Dementia, vol. 6, no. 6, pp. 456-464, 2010.
43. S. C. Gerhardt and C. A. Boast, "Motor activity changes following cerebral ischemia in gerbils are correlated with the degree of neuronal degeneration in hippocampus," Behavioral Neuroscience, vol. 102, no. 2, pp. 301-303, 1988.
44. Y. Karasawa, H. Araki, and S. Otomo, "Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in mongolian gerbils," Stroke, vol. 25, no. 3, pp. 645-650, 1994.
45. M. Milot and H. Plamondon, "Ischemia-induced hyperactivity: effects of dim versus bright illumination on open-field exploration and habituation following global ischemia in rats," Behavioural Brain Research, vol. 192, no. 2, pp. 166-172, 2008.
46. M. R. Milot and H. Plamondon, "Time-dependent effects of global cerebral ischemia on anxiety, locomotion, and habituation in rats," Behavioural Brain Research, vol. 200, no. 1, pp. 173-180, 2009.
47. T. G. Ohk, K.-Y. Yoo, S. M. Park et al., "Neuronal damage using fluoro-jade B histofluorescence and gliosis in the striatum after various durations of transient cerebral ischemia in gerbils," Neurochemical Research, vol. 37, no. 4, pp. 826-834, 2012.
48. R. E. Hartman, J. M. Lee, G. J. Zipfel, and D. F. Wozniak, "Characterizing learning deficits and hippocampal neuron loss following transient global cerebral ischemia in rats," Brain Research, vol. 1043, no. 1-2, pp. 48-56, 2005.
49. M. Von Euler, O. Bendel, T. Bueters, J. Sandin, and G. Von Euler, "Profound but transient deficits in learning and memory after global ischemia using a novel water maze test," Behavioural Brain Research, vol. 166, no. 2, pp. 204-210, 2006.
50. K. D. Langdon, S. Granter-Button, and D. Corbett, "Persistent behavioral impairments and neuroinflammation following global ischemia in the rat," European Journal of Neuroscience, vol. 28, no. 11, pp. 2310-2318, 2008.
51. T. Bueters, M. von Euler, O. Bendel, and G. von Euler, "Degeneration of newly formed CA1 neurons following global ischemia in the rat," Experimental Neurology, vol. 209, no. 1, pp. 114-124, 2008.
52. C. Luo, H. Ren, J.-B. Wan et al., "Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury," Journal of Lipid Research, vol. 55, no. 7, pp. 1288-1297, 2014.
53. W. Cao, A. Drumheller, M. Zaharia, G. Lafond, J.-R. Brunette, and F. B. Jolicoeur, "Effects of experimentally induced ischemia on dopamine metabolism in rabbit retina," Investigative Ophthalmology & Visual Science, vol. 34, no. 11, pp. 3140-3146, 1993.
54. W.A. Pulsinelli and T. E. Duffy, "Regional energy balance in rat brain after transient forebrain ischemia," Journal of Neurochemistry, vol. 40, no. 5, pp. 1500-1503, 1983.
55. L. A. Phebus and J. A. Clemens, "Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites," Life Sciences, vol. 44, no. 19, pp. 1335-1342, 1989.
56. M. Y.-T. Globus, "Role of dopamine in ischemic neuronal damage," Stroke, vol. 20, no. 6, pp. 827-828, 1989.
57. T. Kawano, K. Tsutsumi, H. Miyake, and K. Mori, "Striatal dopamine in acute cerebral ischemia of stroke-resistant rats," Stroke, vol. 19, no. 12, pp. 1540-1543, 1988.
58. A. Slivka, T. S. Brannan, J. Weinberger, P. J. Knott, and G. Cohen, "Increase in extracellular dopamine in the striatum during cerebral ischemia: a study utilizing cerebral microdialysis," Journal of Neurochemistry, vol. 50, no. 6, pp. 1714-1718, 1988.
59. A. Kuruvilla, R. Cherian, D. R. Theodore, and J. Abraham, "Temporal profile of tissue levels of dopamine and its metabolites, HVA and DOPAC following focal cerebral ischaemia in anaesthetized primates," Clinical and Experimental Pharmacology and Physiology, vol. 13, no. 7, pp. 519-524, 1986.
60. K. Ogura, M. Shibuya, Y. Suzuki, M. Kanamori, and I. Ikegaki, "Changes in striatal dopamine metabolism measured by in vivo voltammetry during transient brain ischemia in rats," Stroke, vol. 20, no. 6, pp. 783-787, 1989.
61. T. Brannan, J. Weinberger, P. Knott et al., "Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes," Stroke, vol. 18, no. 1, pp. 108-110, 1987.
62. J. Weinberger, J. Nieves-Rosa, and G. Cohen, "Nerve terminal damage in cerebral ischemia: protective effect of alpha-methylpara-tyrosine," Stroke, vol. 16, no. 5, pp. 864-870, 1985.
63. J. A. Clemens and L. A. Phebus, "Dopamine depletion protects striatal neurons from ischemia-induced cell death," Life Sciences, vol. 42, no. 6, pp. 707-713, 1988.
64. L. Zimmer, S. Delion-Vancassel, G. Durand et al., "Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids," Journal of Lipid Research, vol. 41, no. 1, pp. 32-40, 2000.
65. L. C. Schmued and K. J. Hopkins, "Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration," Brain Research, vol. 874, no. 2, pp. 123-130, 2000.
66. H. D. Cardoso, P. P. Passos, C. J. Lagranha et al., "Differential vulnerability of Substantia nigra and Corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids," Frontiers in Human Neuroscience, vol. 6, article 249, 2012.
67. J.-C. Delpech, C. Madore, C. Joffre et al., "Transgenic increase in n-3/n-6 fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation," Neuropsychopharmacology, vol. 40, no. 3, pp. 525-536, 2015.
68. R. De Caterina, M. I. Cybulsky, S. K. Clinton, M. A. Gimbrone Jr., and P. Libby, "The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 14, no. 11, pp. 1829-1836, 1994.
69. T. A. Babcock, W. S. Helton, D. Hong, and N. J. Espat, "Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-α production," Surgical Infections, vol. 3, no. 2, pp. 145-149, 2002.
70. T. E. Novak, T. A. Babcock, D. H. Jho, W. S. Helton, and N. J. Espat, "NF-κB inhibition by ω-3 fatty acids modulates LPSstimulated macrophage TNF-α-transcription," American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 284, no. 1, pp. L84-L89, 2003.
71. A. A. Nielsen, L. G. M. Jørgensen, J. N. Nielsen et al., "Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids," Alimentary Pharmacology and Therapeutics, vol. 22, no. 11-12, pp. 1121-1128, 2005.
72. I. H. Skuladottir, D. H. Petursdottir, and I. Hardardottir, "The effects of omega-3 polyunsaturated fatty acids on TNF-α and IL-10 secretion by murine peritoneal cells in vitro," Lipids, vol. 42, no. 8, pp. 699-706, 2007.
73. J. X. Kang and K. H. Weylandt, "Modulation of inflammatory cytokines by omega-3 fatty acids," Sub-Cellular Biochemistry, vol. 49, pp. 133-143, 2008.
74. P. C. Calder, "Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?" British Journal of Clinical Pharmacology, vol. 75, no. 3, pp. 645-662, 2013.
75. J. H. Garman, S. Mulroney, M. Manigrasso, E. Flynn, and C. Maric, "Omega-3 fatty acid rich diet prevents diabetic renal disease," American Journal of Physiology-Renal Physiology, vol. 296, no. 2, pp. F306-F316, 2009.
76. A. Razzak, C. Aldrich, T. A. Babcock, A. Saied, and N. J. Espat, "Attenuation of iNOS in an LPS-stimulated macrophage model by omega-3 fatty acids is independent of COX-2 derived PGE2," Journal of Surgical Research, vol. 145, no. 2, pp. 244-250, 2008.
77. C. Suschek, O. Schnorr, and V. Kolb-Bachofen, "The role of iNOS in chronic inflammatory processes in vivo: Is it damagepromoting, protective, or active at all?" Current Molecular Medicine, vol. 4, no. 7, pp. 763-775, 2004.
78. Y. Kobayashi, "The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation," Journal of Leukocyte Biology, vol. 88, no. 6, pp. 1157-1162, 2010.
79. V. Ramirez-Ramirez, M. A. Macias-Islas, G. G. Ortiz et al., "Efficacy of fish oil on serum of TNF α, IL-1 β, and IL-6 oxidative stress markers inmultiple sclerosis treated with interferon beta-1b," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 709493, 8 pages, 2013.
80. N. Blondeau, R. H. Lipsky, M. Bourourou, M.W. Duncan, P. B. Gorelick, and A. M. Marini, "Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-Ready for use in the stroke clinic?" BioMed Research International, vol. 2015, Article ID 519830, 8 pages, 2015.